MYBL2 and osteosarcoma: As a prognostic indicator of unfavorable outcomes in osteosarcoma and a universal marker for immune infiltration across various cancers, MYBL2 exerts regulatory control over proliferation, tumor advancement, and immune cell infiltration within osteosarcoma and broader cancer contexts (47).